查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1888545

美國乳癌診斷影像市場規模、佔有率和趨勢分析報告：按技術、臨床階段、最終用途、地區和細分市場預測（2025-2033 年）

U.S. Breast Cancer Imaging Market Size, Share & Trends Analysis Report By Technology (Mammography System, Magnetic Resonance Imaging -based Systems), By Stage Of Care, By End-use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10個工作天內

價格

美國乳癌診斷影像市場摘要

據估計，2024 年美國乳癌影像市場價值為 5.5788 億美元，預計到 2033 年將達到 10.1217 億美元。

預計2025年至2033年複合年成長率（CAGR）將達到7.42%。市場擴張的主要促進因素是美國乳癌發生率的上升。根據Breastcancer.org網站報導，預計到2025年，美國將有約316,950名女性被診斷出患有侵襲性乳癌，此外還將新增59,080例導管原位癌（DCIS）病例，DCIS是一種非侵襲性乳癌。約16%的乳癌病例發生在50歲以下的女性。同一篇報導指出，乳癌是美國女性最常見的癌症，估計每8名女性中就有1名在一生中會被診斷出罹患乳癌。美國癌症協會表示，由於人口老化、生活方式改變和篩檢技術的進步，乳癌的發生率逐年上升。高發病率和高死亡率推動了對乳房攝影影像服務（包括乳房X光檢查、乳房MRI和數位乳房斷層合成（DBT））的需求，從而推動了市場成長。

政府主導的旨在改善早期檢測和診斷服務可近性的各項措施和篩檢項目，顯著擴大了美國乳癌診斷影像市場。為降低乳癌死亡率，美國預防服務工作小組（USPSTF）建議40至74歲的女性每兩年進行一次乳房X光攝影檢查。建立全國統一的篩檢方案，確保更多女性能夠及時獲得診斷影像服務。此外，為支持早期檢測和治療，美國疾病管制與預防中心（CDC）的國家乳癌和子宮頸癌早期檢測計畫（NBCCEDP）為低收入和醫療服務不足的女性提供高品質的乳癌篩檢和診斷服務。這些項目的數據表明，協調一致的篩檢宣傳活動能夠改善患者預後，實現早期診斷，並促進患者堅持建議的影像檢查計劃。因此，政府推薦的篩檢計畫擴大了先進診斷影像技術（例如數位乳房攝影、乳房磁振造影和數位乳房斷層合成（DBT））的普及範圍，從而推動了美國乳癌診斷影像市場的成長。

診斷影像中心和診斷網路的擴張在美國乳癌診斷影像市場成長中發揮關鍵作用。診斷影像中心通常是門診機構，可以是私人機構，也可以是醫療系統或醫院運作的機構。這些機構配備放射科醫生和內科醫生，他們利用醫學影像診斷和治療疾病，確保對診斷測試結果進行專業解讀。

根據 DEFINITIVE HETHCARE 截至 2025 年 1 月的最新數據，美國約有 15,000 家影像中心，為乳癌診斷服務提供了廣泛的覆蓋。中西部、東北部、西部和西南部的影像中心數量多於東南部。這種廣泛的地理覆蓋使患者能夠更方便地獲得乳房 X 光檢查、乳房 MRI 和超音波等重要服務，同時也有助於早期發現患者並進行細胞監測。這些中心的成長和擴張凸顯了擴展診斷網路的重要性，這有助於改善不同地區患者獲得篩檢和診斷服務的機會，並滿足日益成長的乳癌診斷需求。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章美國乳癌診斷影像市場的變數、趨勢和範圍

  • 市場譜系展望
    • 母市場展望
    • 相關及附隨市場展望
  • 市場動態
  • 乳癌影像診斷市場分析工具
    • 產業分析：波特五力模型
    • PESTEL 分析
  • 乳癌影像診斷市場：檢測數量
  • 乳癌診斷影像市場：平均檢查價格

第4章美國乳癌診斷影像市場：技術預測與趨勢分析

  • 乳癌診斷影像市場：技術波動分析
  • 乳癌影像診斷市場技術展望
  • 市場規模、預測與趨勢分析（2021-2033）
  • 乳房X光攝影系統（2D、3D）
  • 基於磁振造影（MRI）的系統
  • 基於核醫學的系統
  • 基於超音波的系統
  • 其他

第5章美國乳癌診斷影像市場：臨床分期評估與趨勢分析

  • 乳癌診斷影像市場：治療階段變化分析
  • 乳癌影像診斷市場：依治療階段展望
  • 市場規模、預測與趨勢分析（2021-2033）
  • 診斷
  • 預處理計劃
  • 監測
  • 後續觀察

第6章美國乳癌診斷影像市場：終端使用者估算與趨勢分析

  • 乳癌診斷影像市場：最終用途差異分析
  • 乳癌診斷影像市場最終用途展望
  • 市場規模、預測與趨勢分析（2021-2033）
  • 醫院
  • 診斷影像中心
  • 乳癌護理中心
  • 其他

第7章 競爭情勢

  • 市場參與企業分類
  • 主要企業簡介
    • Holigic, Inc.
    • GE Healthcare
    • Siemens Healthineers
    • Seno Medical
    • b-rayZ
    • Analogic Corporation
    • Icad, Inc
    • Clairity, Inc.
    • Fujifilm
    • FONAR Corporation
Product Code: GVR-4-68040-791-1

U.S. Breast Cancer Imaging Market Summary

The U.S. breast cancer imaging market size was estimated at USD 557.88 million in 2024 and is expected to reach USD 1,012.17 million by 2033, growing at a CAGR of 7.42% from 2025 to 2033. A key factor driving market expansion is the rising prevalence of breast cancer in the country. According to Breastcancer.Org In the year 2025, approximately 316,950 women are predicted to be diagnosed with invasive breast cancer in the U.S, along with 59,080 new cases of ductal carcinoma in situ (DCIS), a non-invasive form of the disease. Furthermore, approximately 16% of breast cancer is diagnosed in women under age 50. The article states that breast cancer continues to be the most diagnosed cancer in U.S. women, with an estimated one in eight women expected to be diagnosed in their lifetime. According to American Cancer Society, the incidence has been on the rise through the years due to aging population, lifestyle opportunities, and improvements in detection. The high incidence rates, as well as high mortality rates, has fueled the demand for improving breast imaging services, including mammography, breast MRIs, and digital breast tomosynthesis (DBT), these factors are propelling growth in the market.

By enhancing early detection and access to diagnostic services, government initiatives and screening programs have significantly increased the market for breast cancer imaging in the U.S. In order to reduce the number of deaths from breast cancer, The U.S. Preventive Services Task Force (USPSTF) recommends that women aged 40 to 74 should undergo screening mammography every other year. By establishing uniform screening procedures nationwide, these recommendations ensure that more women receive imaging in a timely manner. In addition, to help with early detection and treatment, the U.S. Centers for Disease Control and Prevention (CDC)'s National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides low-income and underserved women with high-quality breast cancer screening and diagnostic services. These programs' data demonstrate that organized screening campaigns improve patient outcomes, enable earlier diagnosis, and boost adherence to suggested imaging schedules, facilitates earlier diagnosis, and improves patient outcomes. Consequently, government-endorsed screening programs expand access to advanced imaging technologies such as digital mammography, breast MRI, and digital breast tomosynthesis (DBT), thereby driving growth in the U.S. Breast Cancer Imaging market.

The expansion of imaging centers and diagnostic networks is playing a crucial role in the growth of U.S. breast cancer imaging market. Typically, imaging centers are outpatient establishments; some are privately owned, while others are run by healthcare systems or hospitals. These facilities frequently employ radiologists and doctors who diagnose and treat diseases using medical imaging, guaranteeing skilled interpretation of diagnostic tests.

Recent data provided by DEFINITIVE HEALTHCARE as of January 2025 indicates that there are approximately 15,000 imaging centers in the U.S., allowing for widespread access to breast cancer diagnostic services. The Midwest, Northeast, West and Southwest have more imaging centers compared to the Southeast This widespread geographic coverage makes it easier for patients to access important services like mammography, breast MRI, and ultrasound. It also helps with early detection and cell monitoring of patients. The growth and expansion of these centers emphasize the importance of growing diagnostic networks, which improve access for patients in various regions to screening and diagnostic capabilities, and address the growing imaging needs for breast cancer.

U.S. Breast Cancer Imaging Market Report Segmentation

This report forecasts revenue growth at the country level and analyzes the latest industry trends in each sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. breast cancer imaging market report based on technology, stage of care and end-use:

  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Mammography System (2D,3D)
  • Magnetic Resonance Imaging (MRI)-based systems
  • Nuclear Medicine- Based Systems
  • Ultrasound-Based Systems
  • Image-guided Biopsy
  • Others
  • Stage of Care Outlook (Revenue, USD Million, 2021 - 2033)
  • Diagnostics
  • Pre-treatment Planning
  • Monitoring
  • Surveillance (Follow-Up)
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Diagnostic Imaging Centers
  • Breast Care Centers
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology
    • 1.2.2. Stage of Care
    • 1.2.3. End-use
  • 1.3. Estimates and forecasts timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased database
    • 1.5.2. GVR's internal database
    • 1.5.3. Secondary sources
    • 1.5.4. Primary research
    • 1.5.5. Details of primary research
  • 1.6. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.7. Market Formulation & Validation
  • 1.8. Model Details
    • 1.8.1. Commodity flow analysis (Model 1)
    • 1.8.2. Approach 1: Commodity flow approach
    • 1.8.3. Volume price analysis (Model 2)
    • 1.8.4. Approach 2: Volume price analysis
  • 1.9. List of Secondary Sources
  • 1.10. List of Primary Sources
  • 1.11. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology
    • 2.2.2. Stage of Care
    • 2.2.3. End-use outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Breast Cancer Imaging Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising prevalence of breast cancer
      • 3.2.1.2. Government initiatives and screening programs
      • 3.2.1.3. Expansion of imaging centers
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Equipment Costs
      • 3.2.2.2. Maintenance costs
  • 3.3. Breast Cancer Imaging Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape
  • 3.4. Breast Cancer Imaging Market: Number of Procedures
  • 3.5. Breast Cancer Imaging Market: Average Procedure Pricing

Chapter 4. U.S. Breast Cancer Imaging Market: Technology Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Breast Cancer Imaging Market: Technology Movement Analysis
  • 4.3. Breast Cancer Imaging Market by Technology Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5. Mammography System (2D,3D)
    • 4.5.1. Mammography System (2D,3D) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Magnetic Resonance Imaging (MRI)-based Systems
    • 4.6.1. Magnetic Resonance Imaging (MRI)-based Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Nuclear Medicine- Based Systems
    • 4.7.1. Nuclear Medicine-Based Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Ultrasound-Based Systems
    • 4.8.1. Ultrasound-Based Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9. Ultrasound-Based Systems
    • 4.9.1. Ultrasound-Based Systems Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.10. Others
    • 4.10.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Breast Cancer Imaging Market: Stage of Care Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Breast Cancer Imaging Market: Stage of Care Movement Analysis
  • 5.3. Breast Cancer Imaging Market by Stage of Care Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.5. Diagnostics
    • 5.5.1. Diagnostics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Pre-treatment Planning
    • 5.6.1. Pre-treatment Planning Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Monitoring
    • 5.7.1. Monitoring Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Surveillance (Follow-Up)
    • 5.8.1. Surveillance (Follow-Up) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Breast Cancer Imaging Market: End-use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Breast Cancer Imaging Market: End-use Movement Analysis
  • 6.3. Breast Cancer Imaging Market by End-use Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 6.5. Hospitals
    • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Diagnostic Imaging Centers
    • 6.6.1. Diagnostic Imaging Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Breast Care Centers
    • 6.7.1. Breast Care Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Others
    • 6.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Key Company Profiles
    • 7.2.1. Holigic, Inc.
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. GE Healthcare
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Siemens Healthineers
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Seno Medical
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. b-rayZ
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Analogic Corporation
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Icad, Inc
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Clairity, Inc.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Fujifilm
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. FONAR Corporation
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 U.S. Breast Cancer Imaging market, by technology specialty, (USD Million) 2021 - 2033
  • Table 4 U.S. Breast Cancer Imaging market, by stage of care, (USD Million) 2021 - 2033
  • Table 5 U.S. Breast Cancer Imaging market, by end-use, (USD Million) 2021 - 2033

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. Breast Cancer Imaging: market outlook
  • Fig. 9 U.S. Breast Cancer Imaging market competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 U.S. Breast Cancer Imaging market driver impact
  • Fig. 15 U.S. Breast Cancer Imaging market restraint impact
  • Fig. 16 U.S. Breast Cancer Imaging market strategic initiatives analysis
  • Fig. 17 U.S. Breast Cancer Imaging market: technology movement analysis
  • Fig. 18 U.S. Breast Cancer Imaging market: technology outlook and key takeaways
  • Fig. 19 Mammography Systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Magnetic Resonance Imaging (MRI)-Based Systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Nuclear Medicine-Based Systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Ultrasound-Based Systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 (USD Million)
  • Fig. 24 U.S. Breast Cancer Imaging market: stage of care movement analysis
  • Fig. 25 U.S. Breast Cancer Imaging market: stage of care outlook and key takeaways
  • Fig. 26 Diagnostic market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Pre-treatment Planning market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Monitoring market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Surveillance (Follow-Up) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Breast Cancer Imaging market, end- use outlook key takeaways (USD Million)
  • Fig. 31 Breast Cancer Imaging market end- use movement analysis (USD Million), 2024 & 2033
  • Fig. 32 Hospitals' market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Diagnostic Imaging Centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Breast Care Centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Participant categorization- U.S. Breast Cancer Imaging market
  • Fig. 37 Market share of key market players- U.S. Breast Cancer Imaging market